Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
2351
DELISTED
MRC Global
MRC
| $8.3M | ﹤0.01% |
631,332
+563,104
| +825% | +$6.48M |
|
2352
Equinor
EQNR
$97.7B
| $8.29M | ﹤0.01% |
532,977
+57,795
| +12% | +$806K |
|
|
DVAX
2353
DELISTED
Dynavax Technologies
DVAX
| $8.29M | ﹤0.01% |
430,666
-63,316
| -13% | -$1.28M |
|
2354
Ecopetrol
EC
$34.5B
| $8.27M | ﹤0.01% |
960,548
-20,721
| -2% | -$146K |
|
2355
Oshkosh
OSK
$8.79B
| $8.27M | ﹤0.01% |
202,280
+107,223
| +113% | +$3.79M |
|
2356
Sensient Technologies
SXT
$5.26B
| $8.26M | ﹤0.01% |
130,191
-51,143
| -28% | -$3.01M |
|
2357
CALL
Marathon Petroleum
MPC
$92.4B
| $8.26M | ﹤0.01% |
222,200
+177,300
| +395% | +$6.74M |
|
2358
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$603M
| $8.19M | ﹤0.01% |
552,921
| – | – |
|
2359
Emergent Biosolutions
EBS
$373M
| $8.16M | ﹤0.01% |
224,541
-70,408
| -24% | -$2.49M |
|
2360
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $8.13M | ﹤0.01% |
94,250
+1,546
| +2% | +$131K |
|
2361
CALL
BioMarin Pharmaceuticals
BMRN
$11.6B
| $8.12M | ﹤0.01% |
98,500
-286,300
| -74% | -$23.3M |
|
2362
PUT
NXP Semiconductors
NXPI
$57.8B
| $8.11M | ﹤0.01% |
100,000
-32,200
| -24% | -$2.4M |
|
|
MGLN
2363
DELISTED
Magellan Health Services, Inc.
MGLN
| $8.1M | ﹤0.01% |
119,269
+52,916
| +80% | +$3.18M |
|
|
VTLE
2364
DELISTED
Vital Energy
VTLE
| $8.1M | ﹤0.01% |
51,072
+29,617
| +138% | +$4.02M |
|
2365
MBIA
MBI
$261M
| $8.09M | ﹤0.01% |
914,348
+132,870
| +17% | +$968K |
|
2366
Haemonetics
HAE
$3.89B
| $8.09M | ﹤0.01% |
231,128
+211,341
| +1,068% | +$6.83M |
|
2367
Dolby
DLB
$5.51B
| $8.08M | ﹤0.01% |
185,831
+101,930
| +121% | +$3.78M |
|
2368
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $8.05M | ﹤0.01% |
186,636
+7,218
| +4% | +$296K |
|
2369
Myriad Genetics
MYGN
$270M
| $8.05M | ﹤0.01% |
215,058
+81,571
| +61% | +$3.07M |
|
|
ARCX
2370
DELISTED
Arc Logistics Partners LP
ARCX
| $8.04M | ﹤0.01% |
786,051
+7,289
| +0.9% | +$83.6K |
|
2371
Ethan Allen Interiors
ETD
$570M
| $8.04M | ﹤0.01% |
252,696
+22,474
| +10% | +$628K |
|
|
APLP
2372
DELISTED
Archrock Partners, L.P. Common Units representing Limited Partner Interests
APLP
| $8.03M | ﹤0.01% |
725,025
+115,578
| +19% | +$1.01M |
|
2373
Enovis
ENOV
$1.68B
| $8.03M | ﹤0.01% |
163,187
+107,391
| +192% | +$4.57M |
|
2374
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $8M | ﹤0.01% |
212,600
+9,300
| +5% | +$342K |
|
2375
PUT
F5
FFIV
$22.9B
| $7.99M | ﹤0.01% |
75,500
-10,900
| -13% | -$1.04M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.